Pricing Log in Create free account

Cuprina Holdings (Cayman) Limited (CUPR) vs Regentis Biomaterials Ltd. (RGNT)

Cuprina Holdings (Cayman) Limited and Regentis Biomaterials Ltd. are both Medical Instruments & Supplies companies. Cuprina Holdings (Cayman) Limited is the larger, with a market value of $10.4M against $8.2M — 1.3× the size. Across the 4 metrics below, Cuprina Holdings (Cayman) Limited leads on 2 and Regentis Biomaterials Ltd. on 2.

Valuation

Metric CUPR RGNT Medical Instruments & Supplies median
P/E — — 30.28
P/S — — 2.49
P/B n/m n/m 2.34
Price to free cash flow — n/m 23.49
EV/EBITDA n/m n/m 14.87
EV/Sales n/m n/m 2.75
Earnings yield — — 0.00%
Free cash flow yield — 0.00% 0.59%

Profitability

Metric CUPR RGNT Medical Instruments & Supplies median
Gross margin — — 53.60%
Operating margin — — 1.97%
Net margin — — 0.00%
Free cash flow margin — 0.00% 2.36%
Return on equity — 0.00% 0.00%
Return on assets — 0.00% 0.00%
Return on invested capital 0.00% 0.00% 0.13%

Growth

Metric CUPR RGNT Medical Instruments & Supplies median
Revenue growth (TTM) — — 8.97%
EPS growth (last fiscal year) (178.49%) (1,504.65%) 6.51%
Revenue growth, 5-year CAGR — — 8.85%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric CUPR RGNT Medical Instruments & Supplies median
Debt to equity 0.07 0.00 0.10
Current ratio 2.35 5.62 2.47
Net debt to EBITDA 0.57 0.89 0.97

Dividend

Metric CUPR RGNT Medical Instruments & Supplies median
Dividend yield — — 1.02%
Payout ratio — — 0.27

Size

Metric CUPR RGNT Medical Instruments & Supplies median
Market cap 10.43m 8.22m 1.71b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack